Comprehensive Segmental Revision System (SRS)
K-Number: K173411 · 2018-02-08
Device Summary
Frequently Asked Questions
What is the Comprehensive Segmental Revision System (SRS)?
Comprehensive Segmental Revision System (SRS) is a medical device that received FDA 510(k) clearance on 2018-02-08. It is manufactured by Biomet Manufacturing Corp. The 510(k) number is K173411.
When was Comprehensive Segmental Revision System (SRS) approved by the FDA?
Comprehensive Segmental Revision System (SRS) received FDA 510(k) clearance on 2018-02-08, under approval number K173411.
What company makes Comprehensive Segmental Revision System (SRS)?
Comprehensive Segmental Revision System (SRS) is manufactured by Biomet Manufacturing Corp.
What is the FDA product code for Comprehensive Segmental Revision System (SRS)?
The FDA product code for Comprehensive Segmental Revision System (SRS) is PHX.
Related Clinical Trials
Related PubMed Literature
Other Devices by Biomet Manufacturing Corp
Related Devices (Code: PHX)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.